Aug 01, 2014 at 18:05 | Source: Moneycontrol.com
Motilal Oswal is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 1205 in its July 30, 2014 research report.
Aug 01, 2014 at 16:22 | Source: Moneycontrol.com
Dolat Capital is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target of Rs 1309 in its July 30, 2014 research report.
Aug 01, 2014 at 15:12 | Source: Moneycontrol.com
TTK Healthcare Ltd has informed BSE that Mr. K Vaidyanathan, Executive Director of the Company has expressed his desire to retire from the position of Executive Director / Director of the Company, with effect from September 10, 2014, vide his communication dated August 01, 2014.
Aug 01, 2014 at 13:44 | Source: Moneycontrol.com
ICICIdirect.com has recommended hold rating on Cadila Healthcare with a target price of Rs 1059, in its research report dated July 31, 2014.
Aug 01, 2014 at 10:06 | Source: CNBC-TV18
"With hopes of a revival in earnings fading rapidly for these sectors, we believe investors are best advised to stay long sectors where earnings trends remain strong, i.e., NBFCs, consumer discretionary and IT names, followed by healthcare and staples," said Neelkanth Mishra, Credit Suisse.
Jul 31, 2014 at 13:58 | Source: CNBC-TV18
Here are few top buzzing stocks picked by CNBC-TV18's analysts in trade today - IRB Infra, KEC International, Monsanto, Talwalkars, Cadila, Astra Micro and Bajaj Electricals.
Jul 31, 2014 at 13:36 | Source: CNBC-TV18
According to Dharmesh Kant of India Nivesh Securities, one may buy Cadila Healthcare for a target of Rs 1,200 and Exide Industries for a target of Rs 175.
Jul 31, 2014 at 13:28 | Source: Reuters
The FDA has not expressed concerns over the entire facility, said the sources. The US agency communicated its concern to Cadila in a Form 483, a letter in which the agency typically outlines violations of standard manufacturing practices.
Jul 31, 2014 at 11:25 | Source: CNBC-TV18
"We have a buy recommendation on both Sun Pharma and Ranbaxy at this point," Saion Mukherjee, research analyst Nomura said.
Jul 31, 2014 at 09:04 | Source: CNBC-TV18
Vishal Malkan, malkansview.com advises buying India Cements for a target price of Rs 110 and Adani Enterprises for a target price of Rs 450.